Chesnara Plc (LON:CSN)‘s stock had its “buy” rating reissued by analysts at Canaccord Genuity in a research note issued on Tuesday. They currently have a GBX 370 ($4.59) target price on the stock. Canaccord Genuity’s price objective suggests a potential upside of 8.74% from the stock’s previous close.

Other research analysts also recently issued research reports about the company. Panmure Gordon reiterated a “buy” rating and set a GBX 395 ($4.90) price target on shares of Chesnara Plc in a report on Wednesday, August 31st. Shore Capital reiterated a “house stock” rating on shares of Chesnara Plc in a report on Wednesday, August 31st.

Shares of Chesnara Plc (LON:CSN) opened at 337.21 on Tuesday. The firm’s market cap is GBX 426.25 million. The firm’s 50-day moving average price is GBX 321.27 and its 200-day moving average price is GBX 312.27. Chesnara Plc has a 52 week low of GBX 248.25 and a 52 week high of GBX 355.00.

WARNING: This piece of content was originally reported by The Cerbat Gem and is the propert of of The Cerbat Gem. If you are viewing this piece of content on another website, it was copied illegally and republished in violation of United States and international trademark and copyright law. The correct version of this piece of content can be viewed at

Chesnara Plc Company Profile

Chesnara plc is a holding company, which is engaged in the management of life and pension books of business in the United Kingdom and Western Europe. The Company’s segments include CA, S&P, Movestic, The Waard Group and Other Group Activities. The CA segment is a part of it’s the United Kingdom life insurance and pensions run-off portfolio and consists of the business of Countrywide Assured plc.

Receive News & Stock Ratings for Chesnara Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chesnara Plc and related stocks with our FREE daily email newsletter.